Publications by authors named "A De Diego"
Erratum to 'Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough' [Respir Investig 62(6) (2024), 987-994].
Respir Investig
January 2025
Article Synopsis
- This study investigates how the severity of chronic cough affects the quality of life (QoL) and other outcomes for Spanish patients with refractory chronic cough (RCC) or unexplained chronic cough (UCC).
- Patients self-reported cough severity using various tools, and their results were categorized into three groups based on cough severity scores, revealing a direct link between higher severity and worse QoL.
- The findings suggest that patients with more severe coughs reported greater negative impacts on their daily lives, indicating they may need more targeted treatment interventions.
Background: Metabolic syndrome (MetS) is a cluster of medical conditions and risk factors correlating with insulin resistance that increase the risk of developing cardiometabolic health problems. The specific criteria for diagnosing MetS vary among different medical organizations but are typically based on the evaluation of abdominal obesity, high blood pressure, hyperglycemia, and dyslipidemia. A unique, quantitative and independent estimation of the risk of MetS based only on quantitative biomarkers is highly desirable for the comparison between patients and to study the individual progression of the disease in a quantitative manner.
View Article and Find Full Text PDFPurpose: The purpose of this study was to validate the performance of a portable and remotely controlled slit lamp imaging adaptor.
Methods: Twenty patients with anterior eye segment conditions participated in a randomized masked clinical trial. Imaging was performed using a Haag-Streit AG, BX 900 slit lamp biomicroscope and a new slit lamp prototype.
Article Synopsis
- Intravascular lithotripsy (IVL) is effective for treating calcified coronary lesions in patients with stable coronary disease, as shown in a study involving 426 patients across 26 centers in Spain.
- The study found that IVL was successfully delivered in 99% of cases, achieving procedural success in 66% of patients and similar outcomes for both acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) groups.
- The safety analysis showed a relatively low rate of major adverse cardiovascular events (MACE) at 30 days, with 3% overall (1% for CCS and 5% for ACS), indicating that IVL is both safe and effective in real-life clinical settings.